`
`MULTEPLE EXON SKiPPiNG COMPOSiTiONS FOR DMD
`
`CRQSS—REEERENCE TO RELATED APPLESATiON
`
`This appiication ciairns the benefit under 35 USE. § iigte) of US.
`
`Provisionai patent Appiication No. 61/198,416 tiied Qctoper 24, 2908; wherein this
`
`provisionai appiication is incorporated herein by reference in its entirety.
`
`STATEMENT REGARDiNQ SEQUENCE LiSTihiG
`
`The Sequence Listing associated with this appiication is provided in
`
`text format in iieu of a paper copy, and is hereby incorporated by reference into the
`
`specification.
`
`The name of the text
`
`tiie containing the Sequence Listing is
`
`10
`
`i2G178m4’iGMSEQUENCEmLiSTENG.txt. The text tits is 15? K8, was created on
`
`Qctoper 23, 2098 and is being submitted eiectronicaiiy via EESuWep.
`
`FEELD OF THE ENVENTEON
`
`The present
`
`invention reiates to novei antisense compounds and
`
`compositions suitabie for 'iaciiitating exon skipping in the human dystrophin gene.
`
`15
`
`it aiso provides methods for
`
`inducing exon skipping using the antisense
`
`compositions adapted for use in the methods or the invention.
`
`BACKGROUND OF THE ENVENTEQN
`
`Antisense technoiogies are being deveioped using a range of
`
`chemistries to affect gene expression at a variety of different ieveis (transcription,
`
`spiicing, stahiiity, transiationi. Much of that research has focused on the use of
`
`antisense compounds to correct or compensate tor abnormai or disease"
`
`associated genes in a wide range of indications. Antisense moiecuies are ahie to
`
`inhibit gene expression with specificity, and because of this, many research efforts
`
`concerning oiigonucieotides as moduiators of gene expression have focused on
`
`inhibiting the expression of targeted genes or the function of cismacting eiements.
`
`2t)
`
`25
`
`